Clinical Trial Update: Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial (HALT) is evaluating strategies to manage hypertension and prevent cardiovascular adverse events in patients with B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Waldenström Macroglobulinemia

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Lymphocytic Leukemia, Hematopoietic and Lymphoid System Neoplasm | Status: RECRUITING